| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.01 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |